MicroRNA‐29c‐tetrahedral framework nucleic acids: Towards osteogenic differentiation of mesenchymal stem cells and bone regeneration in critical‐sized calvarial defects

Jiafei Sun,Xingyu Chen,Yunfeng Lin,Xiaoxiao Cai
DOI: https://doi.org/10.1111/cpr.13624
IF: 8.755
2024-02-29
Cell Proliferation
Abstract:In this research, we employed sticky ends modified‐tetrahedral framework nucleic acids (stFNAs) as a delivery system for miR29c, referred to as stFNAs‐miR29c. In previous studies, stFNAs have exhibited remarkable capabilities in terms of drug‐loading, endocytosis capacity and stability. Through the use of stFNAs‐miR29c, we effectively addressed the challenges associated with the instability of miR29c and its limited endocytosis ability. Thus, this delivery system improved the efficiency of miR29c transportation and enhanced its biological function. By activating the Wnt pathway, stFNAs‐miR29c successfully increased the expression of RUNX2 and other factors specific to osteogenesis. This process benefited to the increased deposition of mineralised nodules and optimal bone regeneration in critical‐sized bone defects. These findings have significant implications for the broader applications of stFNAs‐miR29c in long‐term tissue regeneration and reconstruction. Certain miRNAs, notably miR29c, demonstrate a remarkable capacity to regulate cellular osteogenic differentiation. However, their application in tissue regeneration is hampered by their inherent instability and susceptibility to degradation. In this study, we developed a novel miR29c delivery system utilising tetrahedral framework nucleic acids (tFNAs), aiming to enhance its stability and endocytosis capability, augment the efficacy of miR29c, foster osteogenesis in bone marrow mesenchymal stem cells (BMSCs), and significantly improve the repair of critical‐sized bone defects (CSBDs). We confirmed the successful synthesis and biocompatibility of sticky ends‐modified tFNAs (stFNAs) and miR29c‐modified stFNAs (stFNAs‐miR29c) through polyacrylamide gel electrophoresis, microscopy scanning, a cell counting kit‐8 assay and so on. The mechanism and osteogenesis effects of stFNAs‐miR29c were explored using immunofluorescence staining, western blotting, and reserve transcription quantitative real‐time polymerase chain reaction. Additionally, the impact of stFNAs‐miR29c on CSBD repair was assessed via micro‐CT and histological staining. The nano‐carrier, stFNAs‐miR29c was successfully synthesised and exhibited exemplary biocompatibility. This nano‐nucleic acid material significantly upregulated osteogenic differentiation‐related markers in BMSCs. After 2 months, stFNAs‐miR29c demonstrated significant bone regeneration and reconstruction in CSBDs. Mechanistically, stFNAs‐miR29c enhanced osteogenesis of BMSCs by upregulating the Wnt signalling pathway, contributing to improved bone tissue regeneration. The development of this novel nucleic acid nano‐carrier, stFNAs‐miR29c, presents a potential new avenue for guided bone regeneration and bone tissue engineering research.
cell biology
What problem does this paper attempt to address?